Sign in to edit your profile (add interests, mentoring, photo, etc.)
    Keywords
    Last Name
    Institution

    Mark Steven Joel Klempner MD

    TitleProfessor
    InstitutionUniversity of Massachusetts Medical School
    DepartmentMedicine
    AddressUniversity of Massachusetts Medical School
    55 Lake Ave North
    Worcester MA 01605
        Bibliographic 
        selected publications
        List All   |   Timeline
        1. Vega NM, Allison KR, Samuels AN, Klempner MS, Collins JJ. Salmonella typhimurium intercepts Escherichia coli signaling to enhance antibiotic tolerance. Proc Natl Acad Sci U S A. 2013 Aug 27; 110(35):14420-5.
          View in: PubMed
        2. Klempner MS, Baker PJ, Shapiro ED, Marques A, Dattwyler RJ, Halperin JJ, Wormser GP. Treatment trials for post-lyme disease symptoms revisited. Am J Med. 2013 Aug; 126(8):665-9.
          View in: PubMed
        3. Klempner MS, Halperin JJ, Baker PJ, Shapiro ED, O'Connell S, Fingerle V, Wormser GP. Lyme borreliosis: the challenge of accuracy. Neth J Med. 2012 Jan; 70(1):3-5.
          View in: PubMed
        4. Klempner MS, Talbot EA, Lee SI, Zaki S, Ferraro MJ. Case records of the Massachusetts General Hospital. Case 25-2010. A 24-year-old woman with abdominal pain and shock. N Engl J Med. 2010 Aug 19; 363(8):766-77.
          View in: PubMed
        5. Chandra A, Wormser GP, Klempner MS, Trevino RP, Crow MK, Latov N, Alaedini A. Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms. Brain Behav Immun. 2010 Aug; 24(6):1018-24.
          View in: PubMed
        6. Feder HM, Johnson BJ, O'Connell S, Shapiro ED, Steere AC, Wormser GP. A critical appraisal of "chronic Lyme disease". N Engl J Med. 2007 Oct 4; 357(14):1422-30.
          View in: PubMed
        7. Klempner MS, Unnasch TR, Hu LT. Taking a bite out of vector-transmitted infectious diseases. N Engl J Med. 2007 Jun 21; 356(25):2567-9.
          View in: PubMed
        8. Zhao Z, McCloud B, Fleming R, Klempner MS. Borrelia burgdorferi-induced monocyte chemoattractant protein-1 production in vivo and in vitro. Biochem Biophys Res Commun. 2007 Jun 29; 358(2):528-33.
          View in: PubMed
        9. Zhao Z, Fleming R, McCloud B, Klempner MS. CD14 mediates cross talk between mononuclear cells and fibroblasts for upregulation of matrix metalloproteinase 9 by Borrelia burgdorferi. Infect Immun. 2007 Jun; 75(6):3062-9.
          View in: PubMed
        10. Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, Krause PJ, Bakken JS, Strle F, Stanek G, Bockenstedt L, Fish D, Dumler JS, Nadelman RB. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006 Nov 1; 43(9):1089-134.
          View in: PubMed
        11. Klempner M. Interview with Mark Klempner, MD, principal investigator, National Emerging Infectious Diseases Laboratories, and associate provost for research, Boston University School of Medicine. Biosecur Bioterror. 2006; 4(2):107-12.
          View in: PubMed
        12. Wormser GP, Kaslow R, Tang J, Wade K, Liveris D, Schwartz I, Klempner M. Association between human leukocyte antigen class II alleles and genotype of Borrelia burgdorferi in patients with early lyme disease. J Infect Dis. 2005 Dec 1; 192(11):2020-6.
          View in: PubMed
        13. Klempner MS, Wormser GH, Wade K, Trevino RP, Tang J, Kaslow RA, Schmid C. A case-control study to examine HLA haplotype associations in patients with posttreatment chronic Lyme disease. J Infect Dis. 2005 Sep 15; 192(6):1010-3.
          View in: PubMed
        14. Drazen JM, Klempner MS. Disaster, water, cholera, vaccines, and hope. N Engl J Med. 2005 Feb 24; 352(8):827.
          View in: PubMed
        15. Premasiri WR, Moir DT, Klempner MS, Krieger N, Jones G, Ziegler LD. Characterization of the surface enhanced raman scattering (SERS) of bacteria. J Phys Chem B. 2005 Jan 13; 109(1):312-20.
          View in: PubMed
        16. Fleming RV, Marques AR, Klempner MS, Schmid CH, Dally LG, Martin DS, Philipp MT. Pre-treatment and post-treatment assessment of the C(6) test in patients with persistent symptoms and a history of Lyme borreliosis. Eur J Clin Microbiol Infect Dis. 2004 Aug; 23(8):615-8.
          View in: PubMed
        17. Klempner MS, Shapiro DS. Crossing the species barrier--one small step to man, one giant leap to mankind. N Engl J Med. 2004 Mar 18; 350(12):1171-2.
          View in: PubMed
        18. Wang XG, Kidder JM, Scagliotti JP, Klempner MS, Noring R, Hu LT. Analysis of differences in the functional properties of the substrate binding proteins of the Borrelia burgdorferi oligopeptide permease (Opp) operon. J Bacteriol. 2004 Jan; 186(1):51-60.
          View in: PubMed
        19. Zhao Z, Chang H, Trevino RP, Whren K, Bhawan J, Klempner MS. Selective up-regulation of matrix metalloproteinase-9 expression in human erythema migrans skin lesions of acute lyme disease. J Infect Dis. 2003 Oct 15; 188(8):1098-104.
          View in: PubMed
        20. Kaplan RF, Trevino RP, Johnson GM, Levy L, Dornbush R, Hu LT, Evans J, Weinstein A, Schmid CH, Klempner MS. Cognitive function in post-treatment Lyme disease: do additional antibiotics help? Neurology. 2003 Jun 24; 60(12):1916-22.
          View in: PubMed
        21. Klempner MS. Controlled trials of antibiotic treatment in patients with post-treatment chronic Lyme disease. Vector Borne Zoonotic Dis. 2002; 2(4):255-63.
          View in: PubMed
        22. Klempner MS, Hu LT, Evans J, Schmid CH, Johnson GM, Trevino RP, Norton D, Levy L, Wall D, McCall J, Kosinski M, Weinstein A. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med. 2001 Jul 12; 345(2):85-92.
          View in: PubMed
        23. Lin B, Kidder JM, Noring R, Steere AC, Klempner MS, Hu LT. Differences in synovial fluid levels of matrix metalloproteinases suggest separate mechanisms of pathogenesis in Lyme arthritis before and after antibiotic treatment. J Infect Dis. 2001 Jul 15; 184(2):174-80.
          View in: PubMed
        24. Klempner MS, Schmid CH, Hu L, Steere AC, Johnson G, McCloud B, Noring R, Weinstein A. Intralaboratory reliability of serologic and urine testing for Lyme disease. Am J Med. 2001 Feb 15; 110(3):217-9.
          View in: PubMed
        25. Lin B, Short SA, Eskildsen M, Klempner MS, Hu LT. Functional testing of putative oligopeptide permease (Opp) proteins of Borrelia burgdorferi: a complementation model in opp(-) Escherichia coli. Biochim Biophys Acta. 2001 Jan 15; 1499(3):222-31.
          View in: PubMed
        26. Hu LT, Klempner MS. Update on the prevention, diagnosis, and treatment of Lyme disease. Adv Intern Med. 2001; 46:247-75.
          View in: PubMed
        27. Klempner M. Navigating life review interviews with survivors of trauma. Oral Hist Rev. 2000 Summer-Fall; 27(2):67-83.
          View in: PubMed
        28. Lin B, Noring R, Steere AC, Klempner MS, Hu LT. Soluble CD14 levels in the serum, synovial fluid, and cerebrospinal fluid of patients with various stages of Lyme disease. J Infect Dis. 2000 Mar; 181(3):1185-8.
          View in: PubMed
        29. Perides G, Tanner-Brown LM, Eskildsen MA, Klempner MS. Borrelia burgdorferi induces matrix metalloproteinases by neural cultures. J Neurosci Res. 1999 Dec 15; 58(6):779-90.
          View in: PubMed
        30. Klempner MS, Huber BT. Is it thee or me?--autoimmunity in Lyme disease. Nat Med. 1999 Dec; 5(12):1346-7.
          View in: PubMed
        31. Klempner MS. Beyond us versus them. J Gen Intern Med. 1999 Aug; 14(8):514-5.
          View in: PubMed
        32. Bozza M, Kyvelos D, Trepicchio WL, Collins M, Klempner MS, Dorner AJ. Recombinant human interleukin-11 does not affect functions of purified human neutrophils in vitro. J Interferon Cytokine Res. 1998 Oct; 18(10):889-95.
          View in: PubMed
        33. Sigal LH, Zahradnik JM, Lavin P, Patella SJ, Bryant G, Haselby R, Hilton E, Kunkel M, Adler-Klein D, Doherty T, Evans J, Molloy PJ, Seidner AL, Sabetta JR, Simon HJ, Klempner MS, Mays J, Marks D, Malawista SE. A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium. N Engl J Med. 1998 Jul 23; 339(4):216-22.
          View in: PubMed
        34. McDermott DF, Trehu EG, Mier JW, Sorce D, Rand W, Ronayne L, Kappler K, Clancy M, Klempner M, Atkins MB. A two-part phase I trial of high-dose interleukin 2 in combination with soluble (Chinese hamster ovary) interleukin 1 receptor. Clin Cancer Res. 1998 May; 4(5):1203-13.
          View in: PubMed
        35. Joiner KA, Powderly WG, Blaser MJ, Klempner MS, Locksley RM, Mandell GL, Preheim LC, Remington JS, Slama TG, Steigbigel NH, Bartlett JG. Fellowship training in infectious diseases: a report from the regional and national meetings of infectious diseases division chiefs and program directors. Clin Infect Dis. 1998 May; 26(5):1060-5.
          View in: PubMed
        36. Friedberg MH, Glantz MJ, Klempner MS, Cole BF, Perides G. Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis. Cancer. 1998 Mar 1; 82(5):923-30.
          View in: PubMed
        37. Perides G, Charness ME, Tanner LM, Péter O, Satz N, Steere AC, Klempner MS. Matrix metalloproteinases in the cerebrospinal fluid of patients with Lyme neuroborreliosis. J Infect Dis. 1998 Feb; 177(2):401-8.
          View in: PubMed
        38. Hu LT, Pratt SD, Perides G, Katz L, Rogers RA, Klempner MS. Isolation, cloning, and expression of a 70-kilodalton plasminogen binding protein of Borrelia burgdorferi. Infect Immun. 1997 Dec; 65(12):4989-95.
          View in: PubMed
        39. Hu LT, Klempner MS. Host-pathogen interactions in the immunopathogenesis of Lyme disease. J Clin Immunol. 1997 Sep; 17(5):354-65.
          View in: PubMed
        40. Hu LT, Perides G, Tanner LM, Klempner MS. Detection of a 130-kD matrix metalloproteinase in cerebrospinal fluid from a patient with Lyme neuroborreliosis. Clin Infect Dis. 1997 Jun; 24(6):1276-7.
          View in: PubMed
        41. Du Bois JS, Trehu EG, Mier JW, Shapiro L, Epstein M, Klempner M, Dinarello C, Kappler K, Ronayne L, Rand W, Atkins MB. Randomized placebo-controlled clinical trial of high-dose interleukin-2 in combination with a soluble p75 tumor necrosis factor receptor immunoglobulin G chimera in patients with advanced melanoma and renal cell carcinoma. J Clin Oncol. 1997 Mar; 15(3):1052-62.
          View in: PubMed
        42. Trehu EG, Mier JW, Dubois JS, Sorce D, Klempner MS, Epstein M, Dinarello CA, Shapiro L, Kappler K, Ronayne L, Atkins MB. Phase I trial of interleukin 2 in combination with the soluble tumor necrosis factor receptor p75 IgG chimera. Clin Cancer Res. 1996 Aug; 2(8):1341-51.
          View in: PubMed
        43. Klempner MS, Noring R, Epstein MP, McCloud B, Rogers RA. Binding of human urokinase type plasminogen activator and plasminogen to Borrelia species. J Infect Dis. 1996 Jul; 174(1):97-104.
          View in: PubMed
        44. Falagas ME, Klempner MS. Babesiosis in patients with AIDS: a chronic infection presenting as fever of unknown origin. Clin Infect Dis. 1996 May; 22(5):809-12.
          View in: PubMed
        45. Perides G, Noring R, Klempner MS. Inhibition of Borrelia burgdorferi-bound fibrinolytic enzymes by alpha2-antiplasmin, PAI-1 and PAI-2. Biochem Biophys Res Commun. 1996 Feb 27; 219(3):690-5.
          View in: PubMed
        46. Hu LT, Perides G, Noring R, Klempner MS. Binding of human plasminogen to Borrelia burgdorferi. Infect Immun. 1995 Sep; 63(9):3491-6.
          View in: PubMed
        47. Klempner MS, Langdon LO. Training in infectious disease: planning for the future. Infect Agents Dis. 1995 Jun; 4(2):110-4.
          View in: PubMed
        48. Klempner MS, Noring R, Epstein MP, McCloud B, Hu R, Limentani SA, Rogers RA. Binding of human plasminogen and urokinase-type plasminogen activator to the Lyme disease spirochete, Borrelia burgdorferi. J Infect Dis. 1995 May; 171(5):1258-65.
          View in: PubMed
        49. Stone DR, Estes NA, Klempner MS. Mycobacterium bovis infection of an implantable defibrillator following intravesical therapy with bacille Calmette-Guérin. Clin Infect Dis. 1993 Jun; 16(6):825-6.
          View in: PubMed
        50. Klempner MS, Noring R, Rogers RA. Invasion of human skin fibroblasts by the Lyme disease spirochete, Borrelia burgdorferi. J Infect Dis. 1993 May; 167(5):1074-81.
          View in: PubMed
        51. Georgilis K, Peacocke M, Klempner MS. Fibroblasts protect the Lyme disease spirochete, Borrelia burgdorferi, from ceftriaxone in vitro. J Infect Dis. 1992 Aug; 166(2):440-4.
          View in: PubMed
        52. Katzen NA, Segal GM, Vannier E, Nerad JL, Klempner MS, Dinarello CA. Comparison of granulocyte-macrophage colony stimulating factor and interleukin-1 production from human peripheral blood mononuclear cells as measured by specific radioimmunoassays. Eur Cytokine Netw. 1992 Jul-Aug; 3(4):365-72.
          View in: PubMed
        53. Schapiro BL, Newburger PE, Klempner MS, Dinauer MC. Chronic granulomatous disease presenting in a 69-year-old man. N Engl J Med. 1991 Dec 19; 325(25):1786-90.
          View in: PubMed
        54. Georgilis K, Noring R, Steere AC, Klempner MS. Neutrophil chemotactic factors in synovial fluids of patients with Lyme disease. Arthritis Rheum. 1991 Jun; 34(6):770-5.
          View in: PubMed
        55. Georgilis K, Steere AC, Klempner MS. Infectivity of Borrelia burgdorferi correlates with resistance to elimination by phagocytic cells. J Infect Dis. 1991 Jan; 163(1):150-5.
          View in: PubMed
        56. Mier JW, Vachino G, Klempner MS, Aronson FR, Noring R, Smith S, Brandon EP, Laird W, Atkins MB. Inhibition of interleukin-2-induced tumor necrosis factor release by dexamethasone: prevention of an acquired neutrophil chemotaxis defect and differential suppression of interleukin-2-associated side effects. Blood. 1990 Nov 15; 76(10):1933-40.
          View in: PubMed
        57. Lindler LE, Klempner MS, Straley SC. Yersinia pestis pH 6 antigen: genetic, biochemical, and virulence characterization of a protein involved in the pathogenesis of bubonic plague. Infect Immun. 1990 Aug; 58(8):2569-77.
          View in: PubMed
        58. Klempner MS, Noring R, Mier JW, Atkins MB. An acquired chemotactic defect in neutrophils from patients receiving interleukin-2 immunotherapy. N Engl J Med. 1990 Apr 5; 322(14):959-65.
          View in: PubMed
        59. Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JW, Cannon JG, Rogers TS, Klempner MS, Weber PC, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med. 1989 Feb 2; 320(5):265-71.
          View in: PubMed
        60. Klempner MS, Styrt B. Prevention of recurrent staphylococcal skin infections with low-dose oral clindamycin therapy. JAMA. 1988 Nov 11; 260(18):2682-5.
          View in: PubMed
        61. Georgilis K, Klempner MS. In vitro effects of omega-3 fatty acids on neutrophil intracellular calcium homeostasis and receptor expression for FMLP and LTB4. Inflammation. 1988 Oct; 12(5):475-90.
          View in: PubMed
        62. Styrt B, Schwartz MA, Klempner MS. Calcium release associated with discharge of specific granule contents from human neutrophils. Biochem Biophys Res Commun. 1988 Aug 15; 154(3):1308-13.
          View in: PubMed
        63. Styrt B, Pollack CR, Klempner MS. An abnormal calcium uptake pump in Chediak-Higashi neutrophil lysosomes. J Leukoc Biol. 1988 Aug; 44(2):130-5.
          View in: PubMed
        64. Styrt B, Klempner MS, Rocklin RE. Comparison of prostaglandins E2 and D2 as inhibitors of respiratory burst in neutrophils from atopic and nonatopic subjects. Inflammation. 1988 Jun; 12(3):213-21.
          View in: PubMed
        65. Ho JL, Klempner MS. Diminished activity of protein kinase C in tetanus toxin-treated macrophages and in the spinal cord of mice manifesting generalized tetanus intoxication. J Infect Dis. 1988 May; 157(5):925-33.
          View in: PubMed
        66. Styrt B, Klempner MS. Lysosomotropic amines modulate neutrophil calcium homeostasis. J Cell Physiol. 1988 May; 135(2):309-16.
          View in: PubMed
        67. Styrt B, Klempner MS. Effects of pH on killing of Staphylococcus aureus and Escherichia coli by constituents of the neutrophil phagolysosome. J Med Microbiol. 1988 Feb; 25(2):101-7.
          View in: PubMed
        68. Styrt B, Klempner MS. Lysosomotropic behavior of adrenergic antagonists in interactions with human neutrophils. Biochem Pharmacol. 1988 Feb 1; 37(3):435-41.
          View in: PubMed
        69. Styrt B, Rocklin RE, Klempner MS. Characterization of the neutrophil respiratory burst in atopy. J Allergy Clin Immunol. 1988 Jan; 81(1):20-6.
          View in: PubMed
        70. Styrt B, Schwartz MA, Klempner MS. Linkage between neutrophil degranulation and calcium discharge. Biochem Biophys Res Commun. 1987 Aug 14; 146(3):1386-91.
          View in: PubMed
        71. Georgilis K, Schaefer C, Dinarello CA, Klempner MS. Human recombinant interleukin 1 beta has no effect on intracellular calcium or on functional responses of human neutrophils. J Immunol. 1987 May 15; 138(10):3403-7.
          View in: PubMed
        72. Dana N, Styrt B, Griffin JD, Todd RF, Klempner MS, Arnaout MA. Two functional domains in the phagocyte membrane glycoprotein Mo1 identified with monoclonal antibodies. J Immunol. 1986 Nov 15; 137(10):3259-63.
          View in: PubMed
        73. Borish L, O'Reilly D, Klempner MS, Rocklin RE. Leukocyte inhibitory factor (LIF) potentiates neutrophil responses to formyl-methionyl-leucyl-phenylalanine. J Immunol. 1986 Sep 15; 137(6):1897-903.
          View in: PubMed
        74. Pollack C, Straley SC, Klempner MS. Probing the phagolysosomal environment of human macrophages with a Ca2+-responsive operon fusion in Yersinia pestis. Nature. 1986 Aug 28-Sep 3; 322(6082):834-6.
          View in: PubMed
        75. Ho JL, Klempner MS. Inhibition of macrophage secretion by tetanus toxin is not directly linked to cytosolic calcium homeostasis. Biochem Biophys Res Commun. 1986 Feb 26; 135(1):16-24.
          View in: PubMed
        76. Styrt B, Klempner MS. Inhibition of neutrophil oxidative metabolism by lysosomotropic weak bases. Blood. 1986 Feb; 67(2):334-42.
          View in: PubMed
        77. Ho JL, Klempner MS. In vitro evaluation of clindamycin in combination with oxacillin, rifampin, or vancomycin against Staphylococcus aureus. Diagn Microbiol Infect Dis. 1986 Feb; 4(2):133-8.
          View in: PubMed
        78. Ho JL, Klempner MS. Tetanus toxin inhibits secretion of lysosomal contents from human macrophages. J Infect Dis. 1985 Nov; 152(5):922-9.
          View in: PubMed
        79. Styrt B, Klempner MS. Modification of interactions between neutrophils and staphylococci by lysosomotropic weak bases. Infect Immun. 1985 Nov; 50(2):415-9.
          View in: PubMed
        80. Styrt B, Rocklin RE, Klempner MS. Inhibition of neutrophil superoxide production by fanetizole. Inflammation. 1985 Sep; 9(3):233-44.
          View in: PubMed
        81. Styrt B, Johnson PC, Klempner MS. Differential lysis of plasma membranes and granules of human neutrophils by digitonin. Tissue Cell. 1985; 17(6):793-800.
          View in: PubMed
        82. Styrt B, Klempner MS. Late-presenting variant of chronic granulomatous disease. Pediatr Infect Dis. 1984 Nov-Dec; 3(6):556-9.
          View in: PubMed
        83. Styrt B, Klempner MS. Leukocyte uptake of daunomycin. Drug Metab Dispos. 1984 Nov-Dec; 12(6):790-1.
          View in: PubMed
        84. Klempner MS. Interactions of polymorphonuclear leukocytes with anaerobic bacteria. Rev Infect Dis. 1984 Mar-Apr; 6 Suppl 1:S40-4.
          View in: PubMed
        85. Lad PM, Glovsky MM, Smiley PA, Klempner M, Reisinger DM, Richards JH. The beta-adrenergic receptor in the human neutrophil plasma membrane: receptor-cyclase uncoupling is associated with amplified GTP activation. J Immunol. 1984 Mar; 132(3):1466-71.
          View in: PubMed
        86. Klempner MS, Styrt B. Alkalinizing the intralysosomal pH inhibits degranulation of human neutrophils. J Clin Invest. 1983 Nov; 72(5):1793-800.
          View in: PubMed
        87. Klempner MS, Styrt B. Alkalinization of the intralysosomal pH by clindamycin and its effects on neutrophil function. J Antimicrob Chemother. 1983 Oct; 12 Suppl C:39-50.
          View in: PubMed
        88. Klempner MS, Cendron M, Wyler DJ. Attachment of plasma membrane vesicles of human macrophages to Leishmania tropica promastigotes. J Infect Dis. 1983 Sep; 148(3):377-84.
          View in: PubMed
        89. Klempner MS, Rocklin RE. Effects of leukocyte inhibitory factor (LIF) on human neutrophil function. Inflammation. 1983 Jun; 7(2):145-53.
          View in: PubMed
        90. Styrt B, Klempner MS. Internal pH of human neutrophil lysosomes. FEBS Lett. 1982 Nov 22; 149(1):113-6.
          View in: PubMed
        91. Klempner MS, Rocklin RE. Specific binding of leukocyte inhibitory factor to neutrophil plasma membranes. J Immunol. 1982 May; 128(5):2040-3.
          View in: PubMed
        92. Tonnesen MG, Klempner MS, Austen KF, Wintroub BU. Identification of a human neutrophil angiotension II-generating protease as cathepsin G. J Clin Invest. 1982 Jan; 69(1):25-30.
          View in: PubMed
        93. Simon GL, Klempner MS, Kasper DL, Gorbach SL. Alterations in opsonophagocytic killing by neutrophils of Bacteroides fragilis associated with animal and laboratory passage: effect of capsular polysaccharide. J Infect Dis. 1982 Jan; 145(1):72-7.
          View in: PubMed
        94. Victor M, Weiss J, Klempner MS, Elsbach P. Phospholipase A2 activity in the plasma membrane of human polymorphonuclear leukocytes. FEBS Lett. 1981 Dec 28; 136(2):298-300.
          View in: PubMed
        95. Klempner MS, Styrt B. Clindamycin uptake by human neutrophils. J Infect Dis. 1981 Nov; 144(5):472-9.
          View in: PubMed
        96. Klempner MS, Mikkelsen RB, Corfman DH, André-Schwartz J. Neutrophil plasma membranes. I. High-yield purification of human neutrophil plasma membrane vesicles by nitrogen cavitation and differential centrifugation. J Cell Biol. 1980 Jul; 86(1):21-8.
          View in: PubMed
        97. Crowley CA, Curnutte JT, Rosin RE, André-Schwartz J, Gallin JI, Klempner M, Snyderman R, Southwick FS, Stossel TP, Babior BM. An inherited abnormality of neutrophil adhesion. Its genetic transmission and its association with a missing protein. N Engl J Med. 1980 May 22; 302(21):1163-8.
          View in: PubMed
        98. Klempner MS, Gallin JI, Balow JE, Van Kammen DP. The effect of hemodialysis and C5a des arg on neutrophil subpopulations. Blood. 1980 May; 55(5):777-83.
          View in: PubMed
        99. Gallin JI, Wright DG, Malech HL, Davis JM, Klempner MS, Kirkpatrick CH. Disorders of phagocyte chemotaxis. Ann Intern Med. 1980 Apr; 92(4):520-38.
          View in: PubMed
        100. Klempner MS, Dinarello CA, Henderson WR, Gallin JI. Stimulation of neutrophil oxygen-dependent metabolism by human leukocytic pyrogen. J Clin Invest. 1979 Oct; 64(4):996-1002.
          View in: PubMed
        101. Parrillo JE, Borst GC, Mazur MH, Iannini P, Klempner MS, Moellering RC, Anderson SE. Endocarditis due to resistant viridans streptococci during oral penicillin chemoprophylaxis. N Engl J Med. 1979 Feb 8; 300(6):296-300.
          View in: PubMed
        102. Klempner MS, Gallin JI. Inhibition of neutrophil Fc receptor function by cotricosteroids. Clin Exp Immunol. 1978 Oct; 34(1):137-42.
          View in: PubMed
        103. Klempner MS, Dinarello CA, Gallin JI. Human leukocytic pyrogen induces release of specific granule contents from human neutrophils. J Clin Invest. 1978 May; 61(5):1330-6.
          View in: PubMed
        104. Klempner MS, Gallin JI. Separation and functional characterization of human neutrophil subpopulations. Blood. 1978 Apr; 51(4):659-69.
          View in: PubMed
        105. Sergent JS, Lockshin MD, Klempner MS, Lipsky BA. Central nervous system disease in systemic lupus erythematosus. Therapy and prognosis. Am J Med. 1975 May; 58(5):644-54.
          View in: PubMed
        For assistance with using Profiles, please refer to the online tutorials or contact UMMS Help Desk or call 508-856-8643.
        Mark's Networks
        Click the "See All" links for more information and interactive visualizations!
        Concepts
        _
        Co-Authors
        _
        Similar People
        _
        Same Department
        Physical Neighbors
        _

        This is an official Page/Publication of the University of Massachusetts Worcester Campus
        Office of the Vice Provost for Research, 55 Lake Ave North, Worcester, Massachusetts 01655
        Questions or Comments? Email: publicaffairs@umassmed.edu Phone: 508-856-1572